Hypoglycemia - 26/11/13
Doi : 10.1016/j.ecl.2013.07.002
Mazen Alsahli, MD a, b, John E. Gerich, MD c, ⁎ 
a Division of Endocrinology, Department of Medicine, Southlake Regional Health Center, 309-531 Davis Drive, Newmarket, Ontario L3Y 6P5, Canada
b Faculty of Medicine, Department of Medicine, University of Toronto, 1 King's College Cir, Toronto, Ontario M5S 1A8, Canada
c Division of Endocrinology, Department of Medicine, University of Rochester School of Medicine, 601 Elmwood Avenue, Rochester, NY 14642, USA
∗Corresponding author. 403 Woodcrest Road, Wayne, PA 19087.
Resumen |
Hypoglycemia remains a common problem for patients with diabetes and is associated with substantial morbidity and mortality. This article summarizes our current knowledge of the epidemiology, pathogenesis, risk factors, and complications of hypoglycemia in patients with diabetes and discusses prevention and treatment strategies.
El texto completo de este artículo está disponible en PDF.Keywords : Type 1 diabetes, Type 2 diabetes, Hypoglycemia, Hypoglycemia counterregulation
Esquema
| Disclosures: Dr Alsahli has nothing to disclose. |
|
| Funding Sources: Dr Gerich: University of Rochester Senior Faculty Associates Program. |
|
| Conflict of Interest: Dr Gerich: Consultant: AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly, Merck, Sanofi-Aventis, and Janssen Pharmaceuticals. |
|
| Speakers' Bureau: AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly, Merck, Sanofi-Aventis, and Janssen Pharmaceuticals. |
© 2013
Elsevier Inc. Reservados todos los derechos.
Vol 42 - N° 4
P. 657-676 - décembre 2013 Regresar al número
Artículo precedente
- Why Focus on Complications?
- Emilia Pauline Liao, Leonid Poretsky
- Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State
- Jelena Maletkovic, Andrew Drexler
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?